Hutchison China MediTech Limited (NASDAQ:HCM) Upgraded at BidaskClub

BidaskClub upgraded shares of Hutchison China MediTech Limited (NASDAQ:HCM) from a buy rating to a strong-buy rating in a research note issued to investors on Thursday, October 5th.

Separately, Canaccord Genuity set a $30.00 target price on Hutchison China MediTech Limited and gave the stock a buy rating in a report on Monday, July 31st.

Shares of Hutchison China MediTech Limited (HCM) opened at 29.86 on Thursday. Hutchison China MediTech Limited has a 52 week low of $10.61 and a 52 week high of $32.03.

WARNING: “Hutchison China MediTech Limited (NASDAQ:HCM) Upgraded at BidaskClub” was first reported by BBNS and is owned by of BBNS. If you are accessing this report on another site, it was illegally stolen and reposted in violation of United States and international copyright and trademark legislation. The legal version of this report can be viewed at https://baseballnewssource.com/markets/hutchison-china-meditech-limited-hcm-upgraded-to-strong-buy-at-bidaskclub/1700522.html.

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. The Manufacturers Life Insurance Company boosted its stake in Hutchison China MediTech Limited by 7.7% in the second quarter. The Manufacturers Life Insurance Company now owns 103,799 shares of the company’s stock valued at $2,420,000 after buying an additional 7,400 shares in the last quarter. Baillie Gifford & Co. boosted its stake in Hutchison China MediTech Limited by 6.1% in the second quarter. Baillie Gifford & Co. now owns 167,547 shares of the company’s stock valued at $3,905,000 after buying an additional 9,655 shares in the last quarter. JPMorgan Chase & Co. acquired a new stake in Hutchison China MediTech Limited in the second quarter valued at about $5,102,000. Renaissance Technologies LLC acquired a new stake in Hutchison China MediTech Limited in the first quarter valued at about $618,000. Finally, Wellington Management Group LLP boosted its stake in Hutchison China MediTech Limited by 7.4% in the first quarter. Wellington Management Group LLP now owns 510,826 shares of the company’s stock valued at $10,190,000 after buying an additional 35,053 shares in the last quarter. 4.06% of the stock is currently owned by institutional investors.

Hutchison China MediTech Limited Company Profile

Hutchison China MediTech Limited (Chi-Med) is a China-based, globally-focused healthcare group. The Company researches, develops, manufactures and sells pharmaceuticals and health-related consumer products. Its Innovation Platform focuses on discovering and developing therapeutics in oncology and autoimmune diseases for the global market.

Receive News & Ratings for Hutchison China MediTech Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hutchison China MediTech Limited and related companies with our FREE daily email newsletter.

 


Latest News

Justin Turner Joining Postseason Legends
Justin Turner Joining Postseason Legends
PED Use Cost Alex Rodriguez Millions and His Reputation
PED Use Cost Alex Rodriguez Millions and His Reputation
Yankees to Send Masahiro Tanaka Against Astros in Game 1
Yankees to Send Masahiro Tanaka Against Astros in Game 1
Red Sox Waste Little Time in Firing John Farrell
Red Sox Waste Little Time in Firing John Farrell
Washington Nationals Sans Strasburg for Game 4 at Wrigley
Washington Nationals Sans Strasburg for Game 4 at Wrigley
Red Sox Beat Houston Sunday to Avoid Elimination
Red Sox Beat Houston Sunday to Avoid Elimination


Leave a Reply

 
© 2006-2017 BBNS.